Dr. Agarwal's Health Care Limited has completed the allotment of 3,37,504 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The allotment, approved by the Nomination and Remuneration Committee through a circular resolution dated January 06, 2026, represents the latest exercise of vested stock options by company employees.

Latest ESOP Allotment Details

The recent share allotment was executed at a uniform exercise price, demonstrating the company's continued commitment to employee participation:

The shares have been allotted under the Dr. Agarwal's Health Care Limited - Employee Stock Option Scheme 2022. All allotted equity shares rank pari passu with the existing equity shares of the company, ensuring equal rights and privileges for the holders.

Updated Share Capital Structure

The latest ESOP exercise has resulted in a significant increase in the company's paid-up equity share capital:

The distinctive number range for the newly allotted shares spans from 31,64,70,003 to 31,68,07,506, with the ISIN code INE943P01029 applicable for demat issuance.

Regulatory Compliance and Documentation

The allotment has been conducted in full compliance with Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company filed the required statement under regulation 10(b) with the recognized stock exchanges on February 24, 2025, receiving filing numbers BSE-224564 and NSE-NSE/LIST/47322.

Company Information

Dr. Agarwal's Health Care Limited operates in the healthcare sector and maintains its registered office at 1st Floor, Buhari Towers, No. 4, Moore's Road, Off Greams Road, Near Asan Memorial School, Chennai-600006. The company's shares are listed on both BSE Limited (Scrip Code: 544350) and National Stock Exchange of India Limited (Symbol: AGARWALEYE), providing liquidity and accessibility to investors across major Indian stock exchanges.

Dr. Agarwal's Health Care Limited has initiated a postal ballot process to seek shareholder approval for the appointment of a new statutory auditor. This move comes as part of the company's pre-merger alignment activities with its subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL).

Key Points of the Postal Ballot

• New Auditor Proposed: M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, is proposed to replace M/s. Deloitte Haskins & Sells.
• Reason for Change: The change is part of pre-merger activities to align the statutory audit function across the group.
• E-voting Period: From November 18 to December 17.
• Proposed Auditor Fee: ₹52.50 lakh for the upcoming financial year.

Background and Rationale

The Board of Directors of Dr. Agarwal's Health Care and its material subsidiary AEHL approved a merger on August 27. Following this, AEHL appointed M/s. S.R. Batliboi & Associates LLP as their Statutory Auditors on September 24.

Dr. Agarwal's Health Care is now seeking to appoint the same audit firm to promote synergy, uniformity, and operational efficiency in audit processes across the group. This alignment is expected to streamline audit and reporting practices for the combined entity post-merger.

Resignation of Current Auditor

M/s. Deloitte Haskins & Sells have resigned effective November 12 to facilitate this change. The company stated that the outgoing auditors have not raised any concerns, and the resignation is solely to enable the appointment of AEHL's existing statutory auditors.

Proposed Auditor Details

M/s. S.R. Batliboi & Associates LLP, if approved, will serve as the Statutory Auditors until the conclusion of the 16th Annual General Meeting of the company. The firm, established in 1949, is part of S.R. Batliboi & Affiliates network and has offices across key Indian cities.

Voting Process

Shareholders can cast their votes electronically through the e-voting system provided by KFin Technologies Limited. The e-voting period is set from 9:00 AM IST on November 18 to 5:00 PM IST on December 17.

This move by Dr. Agarwal's Health Care Limited represents a significant step in their merger process and aims to enhance the efficiency of their audit procedures across the group structure.